What is Clene Inc. (CLNN)?
Clene Inc. is a biotechnology company focused on the development of therapies for neurodegenerative diseases. The company’s research and development efforts center on creating treatments that address conditions such as Parkinson’s disease and other disorders characterized by neuronal damage. Clene utilizes proprietary technologies and scientific approaches to develop drug candidates aimed at modulating disease progression and improving patient outcomes. Its pipeline includes various therapeutic programs at different stages of development. The company collaborates with research institutions and leverages clinical studies to advance its products. Clene’s mission involves addressing unmet medical needs in the field of neurodegeneration through innovative therapeutic solutions.
Clene Inc. Stock Price Today: Live Overview
The price today is shaped by market movements for Clene Inc., priced now at $5.9837. It has experienced a trading range between $5.7863 and $6.5463, with a daily change of -10.4194%.
FAQ: Clene Inc. (CLNN)
What is the current price of CLNN stock?
The current stock price is $5.9837.
Does CLNN pay dividends?
Clene Inc. does not pay dividends.
Does CLNN have a formal corporate presence or regional headquarters in the UAE?
Clene Inc. operates in the UAE through partners and distributors without an official office or subsidiary.
What is CLNN best known for?
Clene Inc. is most famous for its development of nanomedicine therapies.
What assets are typically shown together with CLNN?
Commonly shown alongside CLNN: Millicom International Cellular SA, Axon Enterprise Inc, Oil States International Inc
Latest shares articles



